Vertex clinches Trikafta and other cystic fibrosis drug reimbursement deal in England

Cystic fibrosis (CF) patients and their families in England can rest a little easier this week, thanks to an extended long-term reimbursement deal inked by Vertex Pharmaceuticals and the country’s National Health Service (NHS).